Mad Science and Mad Cows: The Case for EPA Regulation of Prionicidal Substances

October 2004
Citation:
34
ELR 10897
Issue
10
Author
Christopher Busch and Jan Paul Mincarelli

I. Introduction: Confirmation of the Inevitable

On December 23, 2003, the U.S. Department of Agriculture (USDA) announced that it had diagnosed a single Holstein dairy cow near Yakima, Washington, with bovine spongiform encephalopathy (BSE), commonly known as mad cow disease. The cow was sent to the BSE international reference laboratory in Weybridge, England, where the diagnosis was confirmed on Christmas day, finally confirming the cattle industry's worst fears that mad cow disease would one day be detected in American herds. News of this discovery sent an immediate shockwave through the U.S. economy, resulting in declining restaurant stock prices, minimal beef futures trading, and public fear of beef consumption. On December 23, the Washington meat company that had slaughtered the BSE-positive cow voluntarily recalled over 10, pounds of beef that they believed might have been exposed to BSE-infected tissues. On December 24, the USDA Food Safety and Inspection Service (FSIS), the same administrative division that had twice inspected the BSE-positive Holstein before releasing it for use as food for human consumption, mandated the recall of beef from cattle that had been slaughtered in the same plant on the same day as the BSE-infected cow. The infected specimen was shown to be 1 of 81 cows that had been shipped to the United States from Canada on September 4, 2001. The Secretary of Agriculture, Ann Veneman, immediately appointed an international panel of BSE experts to assess the response to the identification of the infected cow, to identify areas for improvement of current BSE safeguards, and to trace the whereabouts of the remaining 80 cattle that entered the United States with the infected cow.

Christopher Busch is a recent graduate of the University of the District of Columbia David A. Clarke School of Law. Prior to law school, he received a B.S. in biology, an M.S. in microbiology, and an M.B.A, all from Texas Tech University. He has authored numerous articles that have appeared in a variety of medical journals and has worked extensively in the area of biomedical research. Jan Paul Mincarelli is a third-year student at George Washington University and will become an associate at King & Spalding L.L.P. in Washington, D.C., in fall 2005. He holds a B.S. degree in biochemistry from Michigan State University. The two authors met while serving as summer law clerks at the U.S. Environmental Protection Agency (EPA) in 2003, and they would like to thank Mike Walker and their attorney mentors in the Toxics and Pesticides Enforcement Division of EPA. Profs. Sonia Suter at George Washington University Law School and Clifford Fedler at Texas Tech University provided a number of helpful comments. The authors also thank their families for their continued support and guidance. Mr. Busch may be contacted at christopherbusch @hotmail.com and Mr. Mincarelli at jmincarelli@law.gwu.edu.
Article File